Lento Bio, Inc.
PrivateLast Round
Seed
May 30, 2023
Total Funding Raised
$3.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lento Bio, Inc. is a biotechnology company developing small-molecule eyedrops to treat presbyopia by restoring ocular lens flexibility.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lento Bio, Inc. Comparables
Compare Lento Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glaukos Corporation | 74% | |
| Novartis | 73% | |
| Orasis Pharmaceuticals | 70% |
Lento Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 30, 2023 | ||||
| Pre Seed | Sep 6, 2022 |
Lento Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Excell Partners | Seed |
| Richmond View Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 796% MoM, from 68 to 609.
- May 30, 2023
$2.9M round led by Excell Partners and Ichor Life Sciences
Lento Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lento Bio, Inc.'s valuation, stock price, and market status.
Is Lento Bio, Inc. a public or private company?
Lento Bio, Inc. is a private company.
What is the current stock price of Lento Bio, Inc.?
Lento Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Lento Bio, Inc. worth (valuation)?
Valuation information for Lento Bio, Inc. is not publicly available.
Can I buy Lento Bio, Inc. stock?
Lento Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lento Bio, Inc.'s last funding round?
Lento Bio, Inc.'s most recent funding round was Seed on September 6, 2022.
Who are the main investors in Lento Bio, Inc.?
Key investors in Lento Bio, Inc. include Richmond View Ventures.
Will Lento Bio, Inc. IPO soon?
No public IPO plans have been announced for Lento Bio, Inc..
How can I track Lento Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lento Bio, Inc.'s secondary market activity and sign up for updates.